GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation (Webwire)
Litigation continues between Pronova BioPharma and two other generic challengers - - GlaxoSmithKline (GSK), which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in the US and Puerto Ri...
Share With Friends: 




|
| Industry - Pharmaceutical Stories, RSS Feeds and Widgets via Feedzilla.







|
|